Business UpdateAug 7, 2026, 04:09 PM
Splash Beverage Shifts to Cannabinoid Market; Faces Delisting Risk
AI Summary
Splash Beverage Group is undergoing a significant strategic shift, transitioning from its beverage business to focus on the cannabinoid and wellness markets, highlighted by the acquisition of exclusive worldwide rights to CannEpil®. This pivot comes amidst severe financial distress, including a going concern warning from auditors, recurring operating losses of $25.2 million in 2025, and ongoing NYSE American delisting risks due to equity non-compliance and low stock price. The company has filed an S-1 to register shares for an Equity Line of Credit, potentially raising up to $30.78 million to support its new direction and address financial needs, following a one-for-four reverse stock split.
Key Highlights
- Splash Beverage is transitioning from a beverage business to focus on cannabinoid and wellness economy businesses.
- The company acquired exclusive worldwide rights to CannEpil®, a CBD and THC formulation for epilepsy, on July 6, 2026.
- An S-1 registration statement was filed for the resale of up to 5,000,000 shares by C/M Capital Master Fund, LP under an Equity Line of Credit.
- Splash Beverage may receive up to $30,782,793 in gross proceeds from sales to the Selling Stockholder for working capital.
- Auditors raised substantial doubt about the company's ability to continue as a going concern due to recurring losses.
- The NYSE American accepted a compliance plan for stockholders' equity non-compliance, with a deadline of January 29, 2027.
- A one-for-four reverse stock split became effective on July 24, 2026, following a trading halt due to the stock price falling below $0.10.
- The company reported a net loss from continuing operations of approximately $25.2 million for the year ended December 31, 2025.
Price Impact
More from SBEV